Eyad Elkord - Concepedia

Author

Eyad Elkord

Hamad bin Khalifa University ORCID

Also Known As

E Elkord, E. Elkord, Elkord Eyad, Elkord, Eyad, Eyad Elkord

171

Publications

12.3K

Citations

H-Index

Concepts

All Affiliations

Hamad bin Khalifa University Qatar Foundation University of Manchester Cancer Research UK Manchester Institute University of Salford

About

Eyad Elkord is an author at Hamad bin Khalifa University specializing in medicine, immunology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	28	1.4K
2	Cell Biology	12	14	682
3	Allergy	3	3	247
4	Health Sciences	1	1	62
5	Cellular Therapies	1	1	34

Eyad Elkord

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma Christy Ralph, Eyad Elkord, Deborah J. Burt, Clinical Cancer Research	2010	249
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia Sai Daayana, Eyad Elkord, Ursula Winters, British Journal of Cancer	2010	246
Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19 Hibah Shaath, Radhakrishnan Vishnubalaji, Eyad Elkord, Cells	2020	205
Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival Richard W. Griffiths, Eyad Elkord, David E. Gilham, Cancer Immunology Immunotherapy UrologyCancer ImmunosurveillanceGenitourinary CancerMedicineT-regulatory Cell	2007	194
Human monocyte isolation methods influence cytokine production from <i>in vitro</i> generated dendritic cells Eyad Elkord, P Williams, Howard Kynaston, Immunology ImmunologyImmunologic MechanismCd4 T Cell ResponsesImmunotherapyImmune System	2005	156
Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients Salman M. Toor, Khaled Murshed, Mahmood Al‐Dhaheri, Frontiers in Immunology	2019	152
DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer Varun Sasidharan Nair, Haytham El Salhat, Rowaida Z. Taha, Clinical Epigenetics	2018	142
Increased Levels of Granulocytic Myeloid-Derived Suppressor Cells in Peripheral Blood and Tumour Tissue of Pancreatic Cancer Patients Yazan S. Khaled, Basil J. Ammori, Eyad Elkord Journal of Immunology Research ImmunologyPathologyPeripheral BloodImmunotherapeuticsImmunotherapy	2014	131
Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer Reem Saleh, Rowaida Z. Taha, Salman M. Toor, Cancer Immunology Immunotherapy	2020	131
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment Azharuddin Sajid Syed Khaja, Salman M. Toor, Haytham El Salhat, Oncotarget	2017	123

Page 1